PT  - JOURNAL ARTICLE
AU  - Sara Monti
AU  - Carlomaurizio Montecucco
TI  - Clinical course and outcome of COVID-19 in patients with rheumatic diseases: are all biological disease-modifying antirheumatic drugs alike? Response to: ‘Increased risk for severe COVID-19 in patients with inflammatory rheumatic diseases treated with rituximab’ by Schulze-Koops <em>et al</em>
AID  - 10.1136/annrheumdis-2020-218148
DP  - 2020 Jun 26
TA  - Annals of the Rheumatic Diseases
PG  - annrheumdis-2020-218148
4099  - http://ard.bmj.com/content/early/2020/06/25/annrheumdis-2020-218148.short
4100  - http://ard.bmj.com/content/early/2020/06/25/annrheumdis-2020-218148.full